Prognostic value of liver fibrosis and steatosis biomarkers in type‐2 diabetes and dyslipidaemia
Perazzo, H., Munteanu, M., Ngo, Y., Lebray, P., Seurat, N., Rutka, F., Couteau, M., Jacqueminet, S., Giral, P., Monneret, D., Imbert‐Bismut, F., Ratziu, V., Hartemann‐Huertier, A., Housset, C., Poynard, T.
Published in Alimentary pharmacology & therapeutics (01.11.2014)
Published in Alimentary pharmacology & therapeutics (01.11.2014)
Get full text
Journal Article
P1024 PRESENCE OF HEPATIC STEATOSIS AS PER NON-INVASIVE BIOMARKERS OVERESTIMATES FIBROSIS STAGES BASED ON LIVER STIFFNESS MEASUREMENT (LSM) BY TRANSIENT ELASTOGRAPHY IN TYPE-2 DIABETIC (T2D) PATIENTS
Perazzo, H, Munteanu, M, Ngo, Y, Lebray, P, Lukina, E, Seurat, N, Rutka, F, Couteau, M, Jacqueminet, S, Monneret, D, Imbert-Bismut, F, Ratziu, V, Hartemann-Huertier, A, Housset, C, Poynard, T
Published in Journal of hepatology (01.04.2014)
Published in Journal of hepatology (01.04.2014)
Get full text
Journal Article
The Guanine Nucleotide Exchange Factors Trio, Ect2, and Vav3 Mediate the Invasive Behavior of Glioblastoma
Salhia, Bodour, Tran, Nhan L, Chan, Amanda, Wolf, Amparo, Nakada, Mitsutoshi, Rutka, Fiona, Ennis, Matthew, McDonough, Wendy S, Berens, Michael E, Symons, Marc, Rutka, James T
Published in The American journal of pathology (01.12.2008)
Published in The American journal of pathology (01.12.2008)
Get full text
Journal Article